Is a Booster Dose Necessary in Children after Immunization with Live Attenuated Japanese Encephalitis Vaccine?

被引:5
作者
Choi, Ui Yoon [1 ]
Lee, Soo Young [1 ]
Kim, Ki Hwan [2 ]
Kim, Dong Soo [2 ]
Choi, Kyong Min [3 ]
Cha, Sung Ho [4 ]
Kang, Jin Han [1 ]
机构
[1] Catholic Univ Korea, Dept Pediat, Coll Med, Seoul 137701, South Korea
[2] Yonsei Univ, Coll Med, Dept Pediat, Seoul, South Korea
[3] Naeun Hosp, Dept Pediat, Inchon, South Korea
[4] Kyung Hee Univ, Coll Med, Dept Pediat, Seoul, South Korea
关键词
Japanese encephalitis; live attenuated Japanese encephalitis vaccine; booster; immunogenicity; safety; NEPALESE CHILDREN; SA14-14-2; SAFETY; RESPONSES; DENGUE;
D O I
10.1093/tropej/fmt043
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Japanese encephalitis virus is a common cause of encephalitis in Asian children; therefore, maintenance of immunity against Japanese encephalitis virus is essential. Although many countries recommend booster vaccination, some trials have concluded that administration of one or two vaccinations is sufficient. The current study was conducted to evaluate immunogenicity and safety after a booster vaccination with live attenuated vaccine. For 68 study subjects, measurement of antibody titer was performed before and at 4-6 weeks after administration of a booster dose. Adverse reactions occurring at the injection site and systemic adverse reactions were documented. The percentages of subjects with seroprotective neutralizing antibody titers was 100% before and after booster vaccination, and the geometric mean titer increased after booster vaccination. Thus, we predict that immunity will be maintained for a long time by an amnestic response. Low percentages of adverse reactions indicated the safety of the immunizations.
引用
收藏
页码:423 / 425
页数:3
相关论文
共 50 条
  • [31] Use of the live attenuated Japanese Encephalitis vaccine SA 14-14-2 in children: A review of safety and tolerability studies
    Ginsburg, Amy Sarah
    Meghani, Ankita
    Halstead, Scott B.
    Yaich, Mansour
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (10) : 2222 - 2231
  • [32] Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine
    Tretyakova, Irina
    Lukashevich, Igor S.
    Glass, Pamela
    Wang, Eryu
    Weaver, Scott
    Pushko, Peter
    VACCINE, 2013, 31 (07) : 1019 - 1025
  • [33] Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities
    Yu, Yongxin
    VACCINE, 2010, 28 (21) : 3635 - 3641
  • [34] Investigation of immune response induction by Japanese encephalitis live-attenuated and chimeric vaccines in mice
    Fang, Enyue
    Liu, Xinyu
    Liu, Xiaohui
    Li, Ming
    Wang, Ling
    Li, Miao
    Zhang, Zelun
    Li, Yuhua
    Yu, Yongxin
    MEDCOMM, 2022, 3 (02):
  • [35] Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51
    Dubischar-Kastner, Katrin
    Eder, Susanne
    Buerger, Vera
    Gartner-Woelfl, Gabriele
    Kaltenboeck, Astrid
    Schuller, Elisabeth
    Tauber, Erich
    Klade, Christoph
    VACCINE, 2010, 28 (32) : 5197 - 5202
  • [36] Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines
    Capeding, Maria Rosario
    Alberto, Edison R.
    Bouckenooghe, Alain
    Laot, Thelma M.
    Chansinghakul, Danaya
    Monfredo, Celine
    Machabert, Tifany
    Feroldi, Emmanuel
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (04) : 567 - 571
  • [37] Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India
    Bonaparte, Matthew
    Dweik, Bashir
    Feroldi, Emmanuel
    Meric, Claude
    Bouckenooghe, Alain
    Hildreth, Stephen
    Hu, Branda
    Yoksan, Sutee
    Boaz, Mark
    BMC INFECTIOUS DISEASES, 2014, 14
  • [38] Influenza Vaccination with a Live Attenuated Vaccine The role of the pediatric nurse in immunization compliance
    Michael, Michele
    Helm, Elizabeth
    Van Graafeiland, Brigit
    Malinoski, Frank
    Bauman, Jay
    AMERICAN JOURNAL OF NURSING, 2009, 109 (10) : 44 - 48
  • [39] Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India
    Shah, Nitin
    Faridi, M. M. A.
    Bhave, Sheila
    Ghosh, Apurba
    Balasubramanian, S.
    Arankalle, Vidya
    Shah, Raju
    Chitkara, Amar Jeet
    Wadhwa, Arun
    Chaudhry, Jaydeep
    Srinivasan, Ramesh
    Surendranath, M.
    Sapru, Amita
    Mitra, Monjori
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [40] Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17
    Shah, PS
    Tanaka, M
    Khan, AH
    Mathenge, EGM
    Fuke, I
    Takagi, M
    Igarashi, A
    Morita, K
    VACCINE, 2006, 24 (04) : 402 - 411